These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2702650)

  • 21. Endometrial adenocarcinoma estrogen receptor content: association of clinicopathologic features with immunohistochemical analysis compared with standard biochemical methods.
    Mutch DG; Soper JT; Budwit-Novotny DA; Cox EB; Creasman WT; McCarty KS; McCarty KS
    Am J Obstet Gynecol; 1987 Oct; 157(4 Pt 1):924-31. PubMed ID: 3314520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased expression of human macrophage metalloelastase (MMP-12) is associated with the invasion of endometrial adenocarcinoma.
    Yang X; Dong Y; Zhao J; Sun H; Deng Y; Fan J; Yan Q
    Pathol Res Pract; 2007; 203(7):499-505. PubMed ID: 17574772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antigen CA 19-9: presence in mucosa of nondiseased müllerian duct derivatives and marker for differentiation in their carcinomas.
    Scharl A; Crombach G; Vierbuchen M; Göhring U; Göttert T; Holt JA
    Obstet Gynecol; 1991 Apr; 77(4):580-5. PubMed ID: 2002982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative quantitative immunohistochemical and immunoradiometric determinations of cathepsin D in endometrial adenocarcinoma: predictors of tumor aggressiveness.
    Nazeer T; Church K; Amato C; Ambros RA; Rosano TG; Malfetano JH; Ross JS
    Mod Pathol; 1994 May; 7(4):469-74. PubMed ID: 8066075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of CD44 alternative splicing variants in primary and lymph node metastatic lesions of gynecological cancer.
    Yorishima T; Nagai N; Ohama K
    Hiroshima J Med Sci; 1997 Mar; 46(1):21-9. PubMed ID: 9114564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paraaortic lymph node evaluation in stage I endometrial carcinoma.
    Piver MS; Lele SB; Barlow JJ; Blumenson L
    Obstet Gynecol; 1982 Jan; 59(1):97-100. PubMed ID: 7078856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carcinoembryonic antigen (CEA) and gastrointestinal cancer associated antigen CA 19-9 in bronchioloalveolar carcinomas and pulmonary adenocarcinomas.
    Heikkilä L; Suomalainen RJ; Lindgren J; Jalanko H; Harjula A; Mattila S
    Ann Chir Gynaecol; 1986; 75(5):260-5. PubMed ID: 3030184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of progesterone receptor immunohistochemistry for lymph node metastases in endometrial carcinoma.
    Iwai K; Fukuda K; Hachisuga T; Mori M; Uchiyama M; Iwasaka T; Sugimori H
    Gynecol Oncol; 1999 Mar; 72(3):351-9. PubMed ID: 10053107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tissue distribution of TAG-72 in malignant mixed müllerian tumors of the uterus.
    Hackett TE; Kaminski P; Olt GJ; Zaino R; Podczaski E
    Gynecol Oncol; 1994 Feb; 52(2):165-71. PubMed ID: 7508876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tamoxifen-associated malignant endometrial tumors: pathologic features and expression of hormone receptors estrogen-alpha, estrogen-beta and progesterone; a case controlled study.
    Wilder JL; Shajahan S; Khattar NH; Wilder DM; Yin J; Rushing RS; Beaven R; Kaetzel C; Ueland FR; van Nagell JR; Kryscio RJ; Lele SM
    Gynecol Oncol; 2004 Feb; 92(2):553-8. PubMed ID: 14766247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. E-cadherin expression in prostate cancer: a broad survey using high-density tissue microarray technology.
    Rubin MA; Mucci NR; Figurski J; Fecko A; Pienta KJ; Day ML
    Hum Pathol; 2001 Jul; 32(7):690-7. PubMed ID: 11486167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fascin immunoreactivity for preoperatively predicting lymph node metastases in peripheral adenocarcinoma of the lung 3 cm or less in diameter.
    Choi PJ; Yang DK; Son CH; Lee KE; Lee JI; Roh MS
    Eur J Cardiothorac Surg; 2006 Sep; 30(3):538-42. PubMed ID: 16870459
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mammaglobin expression in the female genital tract: immunohistochemical analysis in benign and neoplastic endocervix and endometrium.
    Onuma K; Dabbs DJ; Bhargava R
    Int J Gynecol Pathol; 2008 Jul; 27(3):418-25. PubMed ID: 18580321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subcellular localization of blood group Leb carbohydrate antigen (MSN-1-reactive antigen) in endometrial cancer cells.
    Susumu N; Kawakami H; Aoki D; Hirano H; Nozawa S
    Cancer Res; 1993 Aug; 53(15):3643-8. PubMed ID: 8339270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined use of CA 125 and CA 15-3 in patients with endometrial carcinoma.
    Scambia G; Gadducci A; Panici PB; Foti E; Ferdeghini M; Ferrandina G; Amoroso M; Castellani C; Facchini V; Mancuso S
    Gynecol Oncol; 1994 Sep; 54(3):292-7. PubMed ID: 8088605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of EGFR, HER-2/neu, P53, and PCNA in endometrioid, serous papillary, and clear cell endometrial adenocarcinomas.
    Khalifa MA; Mannel RS; Haraway SD; Walker J; Min KW
    Gynecol Oncol; 1994 Apr; 53(1):84-92. PubMed ID: 7909788
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estrogen and progesterone receptors and cyclooxygenase-2 expression in endometrial cancer, endometrial hyperplasia, and normal endometrium.
    Orejuela FJ; Ramondetta LM; Smith J; Brown J; Lemos LB; Li Y; Hollier LM
    Gynecol Oncol; 2005 May; 97(2):483-8. PubMed ID: 15863148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgical staging for patients presenting with grade 1 endometrial carcinoma.
    Ben-Shachar I; Pavelka J; Cohn DE; Copeland LJ; Ramirez N; Manolitsas T; Fowler JM
    Obstet Gynecol; 2005 Mar; 105(3):487-93. PubMed ID: 15738013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Multi-antibody combined determination of lymph node micrometastasis in patients with gastric cancer].
    Wang GY; Wang SJ; Li Y; Wang LL; Wang XL; Song ZC; Fan LQ
    Ai Zheng; 2004 May; 23(5):559-63. PubMed ID: 15142454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prognostic significance of tumor-associated antigen 22-1-1 expression in adenocarcinoma of the uterine cervix.
    Kaku T; Sonoda K; Kamura T; Hirakawa T; Sakai K; Amada S; Ogawa S; Kobayashi H; Nakashima M; Watanabe T; Nakano H
    Clin Cancer Res; 1999 Jun; 5(6):1449-53. PubMed ID: 10389931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.